Document is current

Any future updates will be listed below

A pharmacovigilance study of vortioxetine based on data from the FDA adverse event reporting system

Crossref DOI link: https://doi.org/10.1038/s41598-025-13786-7

Published Online: 2025-08-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark